A. Hagiwara et al., PREVENTION OF PERITONEAL METASTASIS OF CANCER WITH DEXTRAN SULFATE - AN EXPERIMENTAL-STUDY IN MICE, Anti-cancer drugs, 8(9), 1997, pp. 894-897
Peritoneal metastases occur most often in the greater omentum, where t
umor implantation sites are densely distributed. We used dextran sulfa
te (S-Dex) as an anti-cell-adherence agent to prevent i.p. seeded mali
gnant cells from causing peritoneal metastases. S-Dex was tested for i
ts antiadherent activity against B-16 melanoma cells on plastic, and w
as examined for its ability to prevent implantation in the omentum and
to improve survival in mice after B-16 melanoma was inoculated i.p. S
-Dex prevented B-16 melanoma cells from adhering to the plastic wall.
S-Dex reduced the number of B-16 melanoma cells implanted into the gre
ater omentum and improved the survival of mice inoculated with B-16 me
lanoma cells. We conclude that S-Dex attenuated peritoneal metastases
when B-16 melanoma cells were seeded i.p.